Cargando…

Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer

Partial suppression of mitochondrial oxidative phosphorylation and the concurrent activation of aerobic glycolysis is a hallmark of proliferating cancer cells. Overexpression of the ATPase inhibitory factor 1 (IF1), an in vivo inhibitor of the mitochondrial ATP synthase, is observed in most prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Ledo, Lucía, Nuevo-Tapioles, Cristina, Cuevas-Martín, Carmen, Martínez-Reyes, Inmaculada, Soldevilla, Beatriz, González-Llorente, Lucía, Cuezva, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385467/ https://www.ncbi.nlm.nih.gov/pubmed/28443245 http://dx.doi.org/10.3389/fonc.2017.00069

Ejemplares similares

Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells
por: González-Llorente, Lucía, et al.
Publicado: (2019)

Regulation of the H(+)-ATP synthase by IF1: a role in mitohormesis
por: Esparza-Moltó, Pau B., et al.
Publicado: (2017)

IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential
por: Romero-Carramiñana, Inés, et al.
Publicado: (2023)

Vacuolar Membrane ATPase Activity 21 Predicts a Favorable Outcome and Acts as a Suppressor in Colorectal Cancer
por: Zhang, Fan, et al.
Publicado: (2021)

Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
por: Sánchez-Aragó, M, et al.
Publicado: (2013)

Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
por: Nuevo-Tapioles, Cristina, et al.
Publicado: (2020)

The role of KRAS splice variants in cancer biology
por: Nuevo-Tapioles, Cristina, et al.
Publicado: (2022)

Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis
por: García-Navas, Rósula, et al.
Publicado: (2021)

Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state
por: Santacatterina, Fulvio, et al.
Publicado: (2015)

Generation of mitochondrial reactive oxygen species is controlled by ATPase inhibitory factor 1 and regulates cognition
por: Esparza-Moltó, Pau B., et al.
Publicado: (2021)

ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy
por: Kong, Jian, et al.
Publicado: (2020)

Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells
por: Mascaraque, Marta, et al.
Publicado: (2020)

Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy
por: Torresano, Laura, et al.
Publicado: (2022)

The ATPase Inhibitory Factor 1 is a Tissue-Specific Physiological Regulator of the Structure and Function of Mitochondrial ATP Synthase: A Closer Look Into Neuronal Function
por: Domínguez-Zorita, Sonia, et al.
Publicado: (2022)

Role for the ATPase inhibitory factor 1 in the environmental carcinogen-induced Warburg phenotype
por: Hardonnière, Kévin, et al.
Publicado: (2017)

Dysfunctional oxidative phosphorylation shunts branched‐chain amino acid catabolism onto lipogenesis in skeletal muscle
por: Sánchez‐González, Cristina, et al.
Publicado: (2020)

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study
por: Kähler, Katharina C., et al.
Publicado: (2021)

Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab
por: Adcock, Charles S, et al.
Publicado: (2019)

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations
por: Vázquez-Montero, Lucía, et al.
Publicado: (2023)

An Exceptionally Favorable Response to Etoposide and Cisplatin
por: Valecha, Gautam, et al.
Publicado: (2015)

Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis
por: Santacatterina, Fulvio, et al.
Publicado: (2017)

HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
por: Cavalieri, Stefano, et al.
Publicado: (2023)

Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers
por: Busch, Elena, et al.
Publicado: (2021)

PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8(+) T lymphocytes
por: Ogando, Jesús, et al.
Publicado: (2019)

Metastatic renal cell carcinoma to the prostate and seminal vesicle
por: Wiesen, Brett, et al.
Publicado: (2020)

HER2-positive metastatic breast cancer with brain metastases responds favorably to pyrotinib and trastuzumab-based treatment: A case report and literature review
por: Chen, Min-long, et al.
Publicado: (2023)

Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors
por: Tiwari, Jayesh Kumar, et al.
Publicado: (2022)

The Role of Mitochondrial H(+)-ATP Synthase in Cancer
por: Esparza-Moltó, Pau B., et al.
Publicado: (2018)

Effective therapeutic strategies in a preclinical mouse model of Charcot–Marie–Tooth disease
por: Nuevo-Tapioles, Cristina, et al.
Publicado: (2021)

Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells
por: Egusquiza-Alvarez, Carlos Alejandro, et al.
Publicado: (2021)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)

Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells
por: Mu, Xiaodong, et al.
Publicado: (2013)

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer
por: Chung, Ivy, et al.
Publicado: (2021)

Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells
por: Wei, Xu-Ge, et al.
Publicado: (2021)

RRBP1 depletion of bone metastatic cancer cells contributes to enhanced expression of the osteoblastic phenotype
por: Chen, Rui, et al.
Publicado: (2022)

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
por: Schoenfeld, David A., et al.
Publicado: (2022)

The Favorable Prognostic Factors for Superior Sulcus Tumor: A Systematic Review and Meta-Analysis
por: Hao, Xiaohu, et al.
Publicado: (2020)

Inflammatory myofibroblastic tumor of the urinary bladder: A prognostically favorable spindle cell neoplasm
por: Laylo, John Carlo V., et al.
Publicado: (2020)

The E3 Ubiquitin Ligase Cbl-b Predicts Favorable Prognosis in Breast Cancer
por: Liu, Xiuming, et al.
Publicado: (2020)

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pceer84qnfn815469m1jfe16ma